Related Experiment Videos
Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy
M Mandreoli1, E Beltrandi, M Casadei-Maldini
1Department of Nephrology, Malpighi Hospital, Bologna, Italy.
Abstract:
Minimal change nephrotic syndrome has been reported to be a lymphocyte-mediated disorder. It has been suggested that the secretion of lymphokine(s) is involved in the pathogenesis of MCN and in determining proteinuria. The presence of a soluble form of IL-2 receptor (sIL-2R) has been previously described in the sera of patients with some autoimmune disorders. In this work, we report the detection of high sIL-2R levels, both in the plasma (mean value 844 +/- 436 U/ml versus normal value 276 +/- 86 U/ml) and urine of patients with MCN during the nephrotic phase alone. Instead, when the patients achieve stable remission, sIL-2R levels decrease to within normal values (mean value 332 +/- 272 U/ml). Furthermore, during the nephrotic syndrome we observed a significant inverse relationship between sIL-2R plasma levels and the mitogenic response to PHA (p less than 0.005). Since sIL-2R exerts a down-modulation on T-proliferative expansion, sIL-2R might represent one of the inhibitory serum factors extensively reported in the serum of patients with MCN-induced nephrotic syndrome.
Insights
High levels of soluble Interleukin-2 receptor (sIL-2R) in nephrotic syndrome patients indicate a potential role in disease pathogenesis. These levels decrease during remission, suggesting sIL-2R may be an inhibitory factor in minimal change nephrotic syndrome.
Area of Science:
- Nephrology
- Immunology
- Molecular Biology
Background:
- Minimal change nephrotic syndrome (MCN) is linked to lymphocyte dysfunction.
- Lymphokines are implicated in MCN pathogenesis and proteinuria.
- Soluble Interleukin-2 receptor (sIL-2R) is found in autoimmune disorders.
Purpose of the Study:
- To investigate sIL-2R levels in patients with minimal change nephrotic syndrome.
- To determine the relationship between sIL-2R levels and disease activity.
- To explore the potential role of sIL-2R as an inhibitory factor.
Main Methods:
- Measurement of plasma and urine sIL-2R levels in MCN patients during nephrotic and remission phases.
- Comparison of sIL-2R levels with normal values.
- Assessment of the correlation between plasma sIL-2R levels and T-cell mitogenic response (PHA).
Main Results:
- Elevated plasma and urine sIL-2R levels were detected in MCN patients during the nephrotic phase.
- sIL-2R levels normalized upon achieving stable remission.
- A significant inverse correlation was observed between plasma sIL-2R and PHA response during nephrotic syndrome.
Conclusions:
- High sIL-2R levels are associated with the nephrotic phase of MCN.
- sIL-2R may function as a down-modulatory factor on T-cell proliferation.
- sIL-2R could be one of the inhibitory serum factors contributing to MCN pathogenesis.